Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 91 entries
Sorted by: Best Match Show Resources per page
[60th birth anniversary of Professor Enno Freerksen, M.D].

Arzneimittel-Forschung

Bönicke R, Thumim JH.
PMID: 4922323
Arzneimittelforschung. 1970 Sep;20(9):1274-5.

No abstract available.

Cite
Bönicke R, Thumim JH. Zum 60. Geburtstag von Professor Dr. Dr. Enno Freerksen. [60th birth anniversary of Professor Enno Freerksen, M.D]. Arzneimittelforschung. 1970;20(9):1274-5
Bönicke, R., & Thumim, J. H. (1970). Zum 60. Geburtstag von Professor Dr. Dr. Enno Freerksen. [60th birth anniversary of Professor Enno Freerksen, M.D]. Arzneimittel-Forschung, 20(9), 1274-5.
Bönicke, R, and Thumim, J H. "Zum 60. Geburtstag von Professor Dr. Dr. Enno Freerksen." [60th birth anniversary of Professor Enno Freerksen, M.D]. Arzneimittel-Forschung vol. 20,9 (1970): 1274-5.
Bönicke R, Thumim JH. Zum 60. Geburtstag von Professor Dr. Dr. Enno Freerksen. [60th birth anniversary of Professor Enno Freerksen, M.D]. Arzneimittelforschung. 1970 Sep;20(9):1274-5. German. PMID: 4922323.
Copy Download .nbib Format: NLM
Molecular structures of various alkyldichlorosilanes in the solid state.

Dalton transactions (Cambridge, England : 2003)

Wagler J, Gericke R.
PMID: 28513680
Dalton Trans. 2017 Jul 11;46(27):8875-8882. doi: 10.1039/c7dt00300e.

A series of organodichlorosilanes RR'SiCl

Cite
Wagler J, Gericke R. Molecular structures of various alkyldichlorosilanes in the solid state. Dalton Trans. 2017;46(27):8875-8882doi: 10.1039/c7dt00300e.
Wagler, J., & Gericke, R. (2017). Molecular structures of various alkyldichlorosilanes in the solid state. Dalton transactions (Cambridge, England : 2003), 46(27), 8875-8882. https://doi.org/10.1039/c7dt00300e
Wagler, Jörg, and Gericke, Robert. "Molecular structures of various alkyldichlorosilanes in the solid state." Dalton transactions (Cambridge, England : 2003) vol. 46,27 (2017): 8875-8882. doi: https://doi.org/10.1039/c7dt00300e
Wagler J, Gericke R. Molecular structures of various alkyldichlorosilanes in the solid state. Dalton Trans. 2017 Jul 11;46(27):8875-8882. doi: 10.1039/c7dt00300e. PMID: 28513680.
Copy Download .nbib Format: NLM
Palladium-Catalyzed Enantioselective Addition of Chiral Metal Enolates to In Situ Generated ortho-Quinone Methides.

Angewandte Chemie (International ed. in English)

Göricke F, Schneider C.
PMID: 30278112
Angew Chem Int Ed Engl. 2018 Nov 05;57(45):14736-14741. doi: 10.1002/anie.201809692. Epub 2018 Oct 18.

We describe herein a conceptually novel, cooperative Brønsted acid/base catalyzed process for the conjugate addition of cyclic β-keto esters to ortho-quinone methides both generated in situ. Upon hemiacetalization, densely functionalized chiral chromans with two adjacent quaternary and additionally a...

Cite
Göricke F, Schneider C. Palladium-Catalyzed Enantioselective Addition of Chiral Metal Enolates to In Situ Generated ortho-Quinone Methides. Angew Chem Int Ed Engl. 2018;57(45):14736-14741doi: 10.1002/anie.201809692.
Göricke, F., & Schneider, C. (2018). Palladium-Catalyzed Enantioselective Addition of Chiral Metal Enolates to In Situ Generated ortho-Quinone Methides. Angewandte Chemie (International ed. in English), 57(45), 14736-14741. https://doi.org/10.1002/anie.201809692
Göricke, Fabian, and Schneider, Christoph. "Palladium-Catalyzed Enantioselective Addition of Chiral Metal Enolates to In Situ Generated ortho-Quinone Methides." Angewandte Chemie (International ed. in English) vol. 57,45 (2018): 14736-14741. doi: https://doi.org/10.1002/anie.201809692
Göricke F, Schneider C. Palladium-Catalyzed Enantioselective Addition of Chiral Metal Enolates to In Situ Generated ortho-Quinone Methides. Angew Chem Int Ed Engl. 2018 Nov 05;57(45):14736-14741. doi: 10.1002/anie.201809692. Epub 2018 Oct 18. PMID: 30278112.
Copy Download .nbib Format: NLM
Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines.

Cancers

Chau C, van Doorn R, van Poppelen NM, van der Stoep N, Mensenkamp AR, Sijmons RH, van Paassen BW, van den Ouweland AMW, Naus NC, van der Hout AH, Potjer TP, Bleeker FE, Wevers MR, van Hest LP, Jongmans MCJ, Marinkovic M, Bleeker JC, Jager MJ, Luyten GPM, Nielsen M.
PMID: 31382694
Cancers (Basel). 2019 Aug 04;11(8). doi: 10.3390/cancers11081114.

Germline pathogenic variants in the BRCA1-associated protein-1 (

Cite
Chau C, van Doorn R, van Poppelen NM, et al. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers (Basel). 2019;11(8)doi: 10.3390/cancers11081114.
Chau, C., van Doorn, R., van Poppelen, N. M., van der Stoep, N., Mensenkamp, A. R., Sijmons, R. H., van Paassen, B. W., van den Ouweland, A. M. W., Naus, N. C., van der Hout, A. H., Potjer, T. P., Bleeker, F. E., Wevers, M. R., van Hest, L. P., Jongmans, M. C. J., Marinkovic, M., Bleeker, J. C., Jager, M. J., Luyten, G. P. M., & Nielsen, M. (2019). Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers, 11(8), . https://doi.org/10.3390/cancers11081114
Chau, Cindy, et al. "Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines." Cancers vol. 11,8 (2019). doi: https://doi.org/10.3390/cancers11081114
Chau C, van Doorn R, van Poppelen NM, van der Stoep N, Mensenkamp AR, Sijmons RH, van Paassen BW, van den Ouweland AMW, Naus NC, van der Hout AH, Potjer TP, Bleeker FE, Wevers MR, van Hest LP, Jongmans MCJ, Marinkovic M, Bleeker JC, Jager MJ, Luyten GPM, Nielsen M. Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers (Basel). 2019 Aug 04;11(8). doi: 10.3390/cancers11081114. PMID: 31382694; PMCID: PMC6721807.
Copy Download .nbib Format: NLM
Taxonomic review of the deep water flathead genus .

ZooKeys

Kai Y, Fricke R.
PMID: 29674889
Zookeys. 2018 Feb 27;(740):59-76. doi: 10.3897/zookeys.740.21729. eCollection 2018.

Three valid species of

Cite
Kai Y, Fricke R. Taxonomic review of the deep water flathead genus . Zookeys. 2018;(740):59-76doi: 10.3897/zookeys.740.21729.
Kai, Y., & Fricke, R. (2018). Taxonomic review of the deep water flathead genus . ZooKeys, (740), 59-76. https://doi.org/10.3897/zookeys.740.21729
Kai, Yoshiaki, and Fricke, Ronald. "Taxonomic review of the deep water flathead genus ." ZooKeys vol. ,740 (2018): 59-76. doi: https://doi.org/10.3897/zookeys.740.21729
Kai Y, Fricke R. Taxonomic review of the deep water flathead genus . Zookeys. 2018 Feb 27;(740):59-76. doi: 10.3897/zookeys.740.21729. eCollection 2018. PMID: 29674889; PMCID: PMC5904489.
Copy Download .nbib Format: NLM
Dupilumab facial redness: Positive effect of itraconazole.

JAAD case reports

de Beer FSA, Bakker DS, Haeck I, Ariens L, van der Schaft J, van Dijk MR, de Bruin-Weller MS.
PMID: 31681828
JAAD Case Rep. 2019 Oct 22;5(10):888-891. doi: 10.1016/j.jdcr.2019.07.020. eCollection 2019 Oct.

No abstract available.

Cite
de Beer FSA, Bakker DS, Haeck I, et al. Dupilumab facial redness: Positive effect of itraconazole. JAAD Case Rep. 2019;5(10):888-891doi: 10.1016/j.jdcr.2019.07.020.
de Beer, F. S. A., Bakker, D. S., Haeck, I., Ariens, L., van der Schaft, J., van Dijk, M. R., & de Bruin-Weller, M. S. (2019). Dupilumab facial redness: Positive effect of itraconazole. JAAD case reports, 5(10), 888-891. https://doi.org/10.1016/j.jdcr.2019.07.020
de Beer, Fleur S A, et al. "Dupilumab facial redness: Positive effect of itraconazole." JAAD case reports vol. 5,10 (2019): 888-891. doi: https://doi.org/10.1016/j.jdcr.2019.07.020
de Beer FSA, Bakker DS, Haeck I, Ariens L, van der Schaft J, van Dijk MR, de Bruin-Weller MS. Dupilumab facial redness: Positive effect of itraconazole. JAAD Case Rep. 2019 Oct 22;5(10):888-891. doi: 10.1016/j.jdcr.2019.07.020. eCollection 2019 Oct. PMID: 31681828; PMCID: PMC6818397.
Copy Download .nbib Format: NLM
Phosphoric Acid Catalyzed Formation of Hydrogen-Bonded .

The Journal of organic chemistry

Göricke F, Haseloff S, Laue M, Schneider M, Brumme T, Schneider C.
PMID: 32786622
J Org Chem. 2020 Sep 18;85(18):11699-11720. doi: 10.1021/acs.joc.0c01375. Epub 2020 Aug 26.

A full account of the Brønsted acid catalyzed, enantioselective synthesis of 4

Cite
Göricke F, Haseloff S, Laue M, et al. Phosphoric Acid Catalyzed Formation of Hydrogen-Bonded . J Org Chem. 2020;85(18):11699-11720doi: 10.1021/acs.joc.0c01375.
Göricke, F., Haseloff, S., Laue, M., Schneider, M., Brumme, T., & Schneider, C. (2020). Phosphoric Acid Catalyzed Formation of Hydrogen-Bonded . The Journal of organic chemistry, 85(18), 11699-11720. https://doi.org/10.1021/acs.joc.0c01375
Göricke, Fabian, et al. "Phosphoric Acid Catalyzed Formation of Hydrogen-Bonded ." The Journal of organic chemistry vol. 85,18 (2020): 11699-11720. doi: https://doi.org/10.1021/acs.joc.0c01375
Göricke F, Haseloff S, Laue M, Schneider M, Brumme T, Schneider C. Phosphoric Acid Catalyzed Formation of Hydrogen-Bonded . J Org Chem. 2020 Sep 18;85(18):11699-11720. doi: 10.1021/acs.joc.0c01375. Epub 2020 Aug 26. PMID: 32786622.
Copy Download .nbib Format: NLM
Rapid Iron(III)-Fluoride-Mediated Hydrogen Atom Transfer.

Angewandte Chemie (International ed. in English)

Panda C, Doyle LM, Gericke R, McDonald AR.
PMID: 34582619
Angew Chem Int Ed Engl. 2021 Dec 06;60(50):26281-26286. doi: 10.1002/anie.202112683. Epub 2021 Nov 05.

We anticipate high-valent metal-fluoride species will be highly effective hydrogen atom transfer (HAT) oxidants because of the magnitude of the H-F bond (in the product) that drives HAT oxidation. We prepared a dimeric Fe

Cite
Panda C, Doyle LM, Gericke R, et al. Rapid Iron(III)-Fluoride-Mediated Hydrogen Atom Transfer. Angew Chem Int Ed Engl. 2021;60(50):26281-26286doi: 10.1002/anie.202112683.
Panda, C., Doyle, L. M., Gericke, R., & McDonald, A. R. (2021). Rapid Iron(III)-Fluoride-Mediated Hydrogen Atom Transfer. Angewandte Chemie (International ed. in English), 60(50), 26281-26286. https://doi.org/10.1002/anie.202112683
Panda, Chakadola, et al. "Rapid Iron(III)-Fluoride-Mediated Hydrogen Atom Transfer." Angewandte Chemie (International ed. in English) vol. 60,50 (2021): 26281-26286. doi: https://doi.org/10.1002/anie.202112683
Panda C, Doyle LM, Gericke R, McDonald AR. Rapid Iron(III)-Fluoride-Mediated Hydrogen Atom Transfer. Angew Chem Int Ed Engl. 2021 Dec 06;60(50):26281-26286. doi: 10.1002/anie.202112683. Epub 2021 Nov 05. PMID: 34582619.
Copy Download .nbib Format: NLM
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.

Breast (Edinburgh, Scotland)

Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, Steyerberg EW, Hauptmann M, van de Beek I, van Engelen K, Wevers MR, Gómez García EB, Ausems MGEM, Berger LPV, van Asperen CJ, Adank MA, Collée MJ, Stommel-Jenner DJ, Jager A, Schmidt MK, Hooning MJ.
PMID: 34929424
Breast. 2021 Dec 14;61:98-107. doi: 10.1016/j.breast.2021.12.007. Epub 2021 Dec 14.

AIM: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral breast cancer (CBC). In a nationwide cohort, we investigated the effects of chemotherapeutic agents given for PBC on CBC risk separately in BRCA1 and...

Cite
Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, et al. Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast. 2021;61:98-107doi: 10.1016/j.breast.2021.12.007.
Akdeniz, D., van Barele, M., Heemskerk-Gerritsen, B. A. M., Steyerberg, E. W., Hauptmann, M., van de Beek, I., van Engelen, K., Wevers, M. R., Gómez García, E. B., Ausems, M. G. E. M., Berger, L. P. V., van Asperen, C. J., Adank, M. A., Collée, M. J., Stommel-Jenner, D. J., Jager, A., Schmidt, M. K., & Hooning, M. J. (2021). Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast (Edinburgh, Scotland), 6198-107. https://doi.org/10.1016/j.breast.2021.12.007
Akdeniz, Delal, et al. "Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study." Breast (Edinburgh, Scotland) vol. 61 (2021): 98-107. doi: https://doi.org/10.1016/j.breast.2021.12.007
Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, Steyerberg EW, Hauptmann M, van de Beek I, van Engelen K, Wevers MR, Gómez García EB, Ausems MGEM, Berger LPV, van Asperen CJ, Adank MA, Collée MJ, Stommel-Jenner DJ, Jager A, Schmidt MK, Hooning MJ. Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast. 2021 Dec 14;61:98-107. doi: 10.1016/j.breast.2021.12.007. Epub 2021 Dec 14. PMID: 34929424.
Copy Download .nbib Format: NLM
Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes.

Cancers

Biewald E, Kiefer T, Geismar D, Schlüter S, Manthey A, Westekemper H, Wulff J, Timmermann B, Ketteler P, Schönberger S, Metz KA, Ting S, Göricke S, Bechrakis NE, Bornfeld N.
PMID: 33924716
Cancers (Basel). 2021 Apr 13;13(8). doi: 10.3390/cancers13081862.

Despite the increased risk of subsequent primary tumors (SPTs) external beam radiation (EBRT) may be the only therapeutic option to preserve a retinoblastoma eye. Due to their physical properties, proton beam therapy (PBT) offers the possibility to use the...

Cite
Biewald E, Kiefer T, Geismar D, et al. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers (Basel). 2021;13(8)doi: 10.3390/cancers13081862.
Biewald, E., Kiefer, T., Geismar, D., Schlüter, S., Manthey, A., Westekemper, H., Wulff, J., Timmermann, B., Ketteler, P., Schönberger, S., Metz, K. A., Ting, S., Göricke, S., Bechrakis, N. E., & Bornfeld, N. (2021). Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers, 13(8), . https://doi.org/10.3390/cancers13081862
Biewald, Eva, et al. "Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes." Cancers vol. 13,8 (2021). doi: https://doi.org/10.3390/cancers13081862
Biewald E, Kiefer T, Geismar D, Schlüter S, Manthey A, Westekemper H, Wulff J, Timmermann B, Ketteler P, Schönberger S, Metz KA, Ting S, Göricke S, Bechrakis NE, Bornfeld N. Feasibility of Proton Beam Therapy as a Rescue Therapy in Heavily Pre-Treated Retinoblastoma Eyes. Cancers (Basel). 2021 Apr 13;13(8). doi: 10.3390/cancers13081862. PMID: 33924716; PMCID: PMC8069965.
Copy Download .nbib Format: NLM
High-Valent d.

Inorganic chemistry

Unjaroen D, Gericke R, Lovisari M, Nelis D, Mondal P, Pirovano P, Twamley B, Farquhar ER, McDonald AR.
PMID: 31804808
Inorg Chem. 2019 Dec 16;58(24):16838-16848. doi: 10.1021/acs.inorgchem.9b03101. Epub 2019 Dec 05.

Oxygenases have been postulated to utilize d

Cite
Unjaroen D, Gericke R, Lovisari M, et al. High-Valent d. Inorg Chem. 2019;58(24):16838-16848doi: 10.1021/acs.inorgchem.9b03101.
Unjaroen, D., Gericke, R., Lovisari, M., Nelis, D., Mondal, P., Pirovano, P., Twamley, B., Farquhar, E. R., & McDonald, A. R. (2019). High-Valent d. Inorganic chemistry, 58(24), 16838-16848. https://doi.org/10.1021/acs.inorgchem.9b03101
Unjaroen, Duenpen, et al. "High-Valent d." Inorganic chemistry vol. 58,24 (2019): 16838-16848. doi: https://doi.org/10.1021/acs.inorgchem.9b03101
Unjaroen D, Gericke R, Lovisari M, Nelis D, Mondal P, Pirovano P, Twamley B, Farquhar ER, McDonald AR. High-Valent d. Inorg Chem. 2019 Dec 16;58(24):16838-16848. doi: 10.1021/acs.inorgchem.9b03101. Epub 2019 Dec 05. PMID: 31804808.
Copy Download .nbib Format: NLM
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.

Breast (Edinburgh, Scotland)

Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, Steyerberg EW, Hauptmann M, van de Beek I, van Engelen K, Wevers MR, Gómez García EB, Ausems MGEM, Berger LPV, van Asperen CJ, Adank MA, Collée MJ, Stommel-Jenner DJ, Jager A, Schmidt MK, Hooning MJ.
PMID: 34929424
Breast. 2021 Dec 14;61:98-107. doi: 10.1016/j.breast.2021.12.007. Epub 2021 Dec 14.

AIM: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral breast cancer (CBC). In a nationwide cohort, we investigated the effects of chemotherapeutic agents given for PBC on CBC risk separately in BRCA1 and...

Cite
Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, et al. Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast. 2021;61:98-107doi: 10.1016/j.breast.2021.12.007.
Akdeniz, D., van Barele, M., Heemskerk-Gerritsen, B. A. M., Steyerberg, E. W., Hauptmann, M., van de Beek, I., van Engelen, K., Wevers, M. R., Gómez García, E. B., Ausems, M. G. E. M., Berger, L. P. V., van Asperen, C. J., Adank, M. A., Collée, M. J., Stommel-Jenner, D. J., Jager, A., Schmidt, M. K., & Hooning, M. J. (2021). Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast (Edinburgh, Scotland), 6198-107. https://doi.org/10.1016/j.breast.2021.12.007
Akdeniz, Delal, et al. "Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study." Breast (Edinburgh, Scotland) vol. 61 (2021): 98-107. doi: https://doi.org/10.1016/j.breast.2021.12.007
Akdeniz D, van Barele M, Heemskerk-Gerritsen BAM, Steyerberg EW, Hauptmann M, van de Beek I, van Engelen K, Wevers MR, Gómez García EB, Ausems MGEM, Berger LPV, van Asperen CJ, Adank MA, Collée MJ, Stommel-Jenner DJ, Jager A, Schmidt MK, Hooning MJ. Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study. Breast. 2021 Dec 14;61:98-107. doi: 10.1016/j.breast.2021.12.007. Epub 2021 Dec 14. PMID: 34929424; PMCID: PMC8693290.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 91 entries